Daniel Loeb’s Bausch Health BHC Stock Holding History

Daniel Loeb’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-350,000	Closed	-$2.43M	–	35
2025 Q4	$2.43M	Buy	350,000 +250,000	+250%	+$1.64M	0.03%	42
2025 Q3	$645K	Buy	+100,000	New	+$684K	0.01%	44
2014 Q2	–	Sell	-250,000	Closed	-$33M	–	43
2014 Q1	$33M	Buy	+250,000	New	+$34.2M	0.48%	46

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Daniel Loeb's BHC Position: Q1 2026 in Review

Daniel Loeb sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 350,000 shares — an estimated $2.43M sold.

Daniel Loeb first reported a position in BHC in Q1 2014 and held it in 3 quarters. The position peaked at $33M in Q1 2014. 228 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

Daniel Loeb reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
Daniel Loeb sold 350,000 Bausch Health shares in Q1 2026, an estimated $2.43M.
Daniel Loeb first reported a position in Bausch Health in Q1 2014 and held it in 3 quarters.
Daniel Loeb's Bausch Health position peaked at $33M in Q1 2014.
228 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Third Point's 13F filing for Q1 2026, filed 15 May 2026.